Page last updated: 2024-08-26

bosentan anhydrous and Headache

bosentan anhydrous has been researched along with Headache in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benza, RL; Channick, RN; McLaughlin, VV; Olschewski, H; Robbins, IM; Rubin, LJ; Seeger, W; Tapson, VF; Voswinckel, R1
Darstein, C; Dingemanse, J; Mitchell, MI; Phillips, DL; Wrishko, RE; Yu, A1
Birnboeck, H; Eggers, H; Hopfgartner, G; Jonkman, JH; Meyer, J; Schmitt, R; van Marle, S; Viischer, HW; Weber, C1

Trials

3 trial(s) available for bosentan anhydrous and Headache

ArticleYear
Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2011, Volume: 30, Issue:12

    Topics: Administration, Inhalation; Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Bosentan; Double-Blind Method; Drug Therapy, Combination; Epoprostenol; Female; Headache; Humans; Hypertension, Pulmonary; Incidence; Longitudinal Studies; Male; Middle Aged; Nausea; Physical Endurance; Piperazines; Purines; Quality of Life; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Young Adult

2011
Pharmacokinetic interaction between tadalafil and bosentan in healthy male subjects.
    Journal of clinical pharmacology, 2008, Volume: 48, Issue:5

    Topics: Administration, Oral; Adult; Antihypertensive Agents; Area Under Curve; Bosentan; Carbolines; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Interactions; Fatigue; Headache; Humans; Male; Metabolic Clearance Rate; Middle Aged; Phosphodiesterase Inhibitors; Sulfonamides; Tadalafil

2008
Multiple-dose pharmacokinetics, safety, and tolerability of bosentan, an endothelin receptor antagonist, in healthy male volunteers.
    Journal of clinical pharmacology, 1999, Volume: 39, Issue:7

    Topics: Administration, Oral; Antihypertensive Agents; Area Under Curve; Blood Pressure; Bosentan; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin Receptor Antagonists; Gastrointestinal Diseases; Headache; Humans; Male; Metabolic Clearance Rate; Pyrimidines; Sulfonamides; Systole

1999